http://www.exelixis.com
Exelixis, Inc. Company Intro
We drive to deliver results and new medicines to treat and defeat cancer, giving patients hope for the future. Cancer is our cause.
Industry
Healthcare
Exelixis, Inc. Headquaters
1851 Harbor Bay Parkway
Alameda,94502
United States
Exelixis, Inc. Share price
20 Jan 2021 01:36 GMT
$23.76
0.03 (0.13 %)
Exelixis, Inc. Market cap
$7.319 B
WMC RANKING
2021
Exelixis, Inc. # 13
BiotechnologyLatest Exelixis, Inc. News
19 Jan 2021
Angiopoietin 1 Receptor Market Size predicts favorable growth and forecast 2021-2026 | Aerpio Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Exelixis
Teva Pharmaceutical Industries Ltd. Exelixis, Inc. Deciphera Pharmaceuticals, LLC Sanofi Eddingpharm PharmAbcine, Inc. Pfizer Inc. Get a Sample Copy ...
19 Jan 2021
Ureter Cancer Drugs Market is booming worldwide with Altor ...
Major Companies Profiled in this Report Includes: Altor BioScience Corp, Eisai Co Ltd, Exelixis Inc, GlaxoSmithKline Plc, MedImmune LLC, Merck & Co Inc.
19 Jan 2021
Global Gynecological Cancers Market Business Growth Tactics, Future Strategies, Competitive Outlook and Forecast 2027||Merck KGaA, Syndax, Clovis Oncology, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc
... F. Hoffmann-La Roche Ltd, Pfizer Inc., Merck KGaA, Syndax, Clovis Oncology, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Exelixis, Inc., ...
WMC Market Score
WMC Market to Revenue Score
Exelixis, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Exelixis, Inc. | USD | $967,775 | $565,208 | $321,012 | $73,190B | 13 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $569,690B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $347,130B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $603,050B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $274,480B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Exelixis, Inc. Social Followers vs Top 4 Industry Competitors
Exelixis, Inc. Post vs Top 4 Industry Competitors
Exelixis, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Exelixis, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Exelixis, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Exelixis, Inc. | 10.47 | 8.14 | 11.92 | 0 | 0 | 0 | 10.31 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.01 | 28.66 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.20 | 100 | 60 | 0 | 0 | 90.57 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.79 | 86 | 0 | 0 | 99.97 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
